Volume: 6 Issue: 1
Year: 2018, Page: 34-36,
Introduction: Vitiligo is an acquired,idiopathic depigmenting skin disorder characterized by circumscribed depigmented macules and patches, which affects approximately 0.1–2% of the general population worldwide. Zinc is an essential trace element that is necessary for growth and development at all stages of life. Some studies have reported an association between serum zinc levels and vitiligo.
Aim : To measure the serum zinc levels in patients with vitiligo compared to healthy subjects.
Materials and Methods : 35 patients with vitiligo and 35 healthy individual, who were visited various hospitals in Karimnagar, Telangana state taken as cases and controls respectively .The two groups were matched for age and sex. Commercially available Coral kit was used to measure serum zinc levels on CPC-semi auto analyser . The statistical analysis was performed using GRAPHPAD-6 software.
Results :The mean serum level of zinc in vitiligo patients and controls was 35.54 ±11.10 μg/dl, 81.29 ±11.32 μg/dl respectively. The serum zinc level in patients with vitiligo was significantly lower than in healthy controls(p = <0.0001*).
Conclusion : The results of our study revealed a significant association between vitiligo and serum zinc levels.A relative decrease in the serum zinc levels in vitiligo patients can highlight the role of zinc in the pathogenesis of vitiligo.
Keywords: Vitiligo,melanogenesis, serum zinc level.
1. Kovacs SO. Vitiligo. J Am Acad Dermatol 1998;38:647-66.
2. Schallreuter KU, Wood JM, Berger J. Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol 1991;97:1081-5.
3. Prasad AS. Zinc: An overview. Nutrition 1995;11:93-9.
4. Prota G. Progress in the Chemistry of Melanins and related metabolites. Med Res Rev 1988;8:525-56.
5. Spritz RA. The genetics of generalized vitiligo. Curr Dir Autoimmune. 2008;10:244–57.
6. Manolache L, Benea V. Stress in patients with alopecia areata and vitiligo. J Eur Acad Dermatol Venereol. 2007;21:921–8.
7. Lebwohl MG, Heymann WR, Berth-Jones J, Coulson I. 2nd ed. Philadelphia: Mosby Elsevier; 2006. Treatment of skin disease. Comprehensive Therapeutic Strategies; pp. 683– 687.
8. Hale LP. Zinc a-2-glycoprotein regulates melanin production by normal and malignant melanocytes. J Invest Dermatol. 2002;119:464–70.
9. Anchez LM, Chirino AJ, Bjorkman PJ. Crystal structure of human ZAG: A fat-depleting factor related to MHC molecules. Science. 1999;283:1914–9.
10. Namazi MR. Phnytoin as a novel anti-vitiligo weapon. J Autoimmune Dis. 2005;2:11.
11. Mandelcorn-Monson RL, Shear NH, Yau E, Sambhara S, Barber BH, Spaner D, et al. Cytotoxic T lymphocyte reactivity to gp100, melan A/MART I, and tyrosinase, in HLA-A2-positive vitiligo patients. J Invest Dermatol. 2003;121:550–6.
12. Yaghoobi R, Omidian M, Bagherani N. Vitiligo: A review of the published work 2011;38:419-31. J Dermatol. 2011;38:419–31.
13. Park HY, Kosmadaki M, Yaar M, Gilchrest BA. Cellular mechanisms regulating human melanogenesis. Cell Mol Life Sci. 2009;66:1493–506.
14. Schallreuter KU, Kothari S, Chavan B, Spencer JD. Regulation of melanogenesis-- controversies and new concepts. ExpDermatol. 2008;17:395–404.
15. Slominski A, Tobin DJ, Shibahara S, Wortsman J. Melanin pigmentation in mammalian skin and its hormonal regulation. PhysiolRev. 2004;84:1155–228.
16. Jimbow K, Chen H, Park JS, Thomas PD. Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo. Br J Dermatol. 2001;144:55–65.
Venugopal B, Kishan Reddy H. Study of serum Zinc levels in patients with vitiligo of north Telangana. Perspectives in Medical Research 2018;6(1):34-36.